BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36249940)

  • 1. Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE.
    Al Ali L; Jagal J; Joseph J; Ahmed IS; Rawas-Qalaji M
    Saudi Pharm J; 2022 Sep; 30(9):1243-1251. PubMed ID: 36249940
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Abou-Taleb BA; Megallaa MH; Khalafallah NM; Khalil SH
    Drug Dev Ind Pharm; 2020 Feb; 46(2):192-199. PubMed ID: 31937146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHARMACEUTICAL QUALITY OF GENERIC ATORVASTATIN PRODUCTS COMPARED WITH THE INNOVATOR PRODUCT: A NEED FOR REVISING PRICING POLICY IN PALESTINE.
    Shawahna R; Hroub AK; Abed E; Jibali S; Al-Saghir R; Zaid AN
    Acta Pol Pharm; 2016; 73(3):725-30. PubMed ID: 27476290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumers' Perception of Generic Medicines and Evaluation of In Vitro Quality Control Parameters of Locally Manufactured Paracetamol Tablets in Asmara, Eritrea: A Cross-Sectional Study.
    Idris IM; Hassan DN; Hassen HA; Araya RZ; Weldemariam DG
    Biomed Res Int; 2021; 2021():6642826. PubMed ID: 34150909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemical and pharmaceutical equivalence of sulphadoxine/pyrimethamine tablets sold on the Tanzanian market.
    Hebron Y; Tettey JN; Pournamdari M; Watson DG
    J Clin Pharm Ther; 2005 Dec; 30(6):575-81. PubMed ID: 16336290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacists' attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan.
    Bashaar M; Hassali MA; Saleem F
    J Pharm Policy Pract; 2015; 8(1):16. PubMed ID: 26078869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the In-Vitro Dissolution Permeation Systems 1 (IDAS1) as a potential tool to monitor for unexpected changes in generic medicaments in poorly regulated markets.
    Rodriguez N; Grosso M; Galvez B; Calderon G; Lau L; Turner VA; Hidalgo IJ
    Eur J Pharm Sci; 2021 Jun; 161():105791. PubMed ID: 33691154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interchangeability between paracetamol tablets marketed in Palestine. Is there a quality reason for a higher price?
    Zaid A; Rinno T; Jaradat N; Jodeh S; Khammash S
    East Mediterr Health J; 2013 Jun; 19(6):542-6. PubMed ID: 24975183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative potency and dissolution performance of internationally available piroxicam products.
    Barone JA
    Pharmacoeconomics; 1992; 1(Suppl 1):49-52. PubMed ID: 10146932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Survey of the Criteria Used for the Selection of Alternative Comparator Products by Participating Regulators and Organizations of the International Pharmaceutical Regulators Programme.
    Tam A; Garcia-Arieta A; Abalos I; Agostinho Freitas Fernandes E; Mendes Lima Santos G; Rodriguez Martinez Z; Divinsky M; Kariv R; Potthast H; Braddy AC; Rodrigues C; Guzman Aurela E; Carolina Arevalo Gonzalez L; Gutierres Triana D; Jones B; Ahn C; Kim H; Kim SH; Kuribayashi R; Myoenzono A; Shimojo K; Van Oudtshoorn J; Bigler C; Meincke R; Roost MS; Walther C; Hsu LF; Crane C; Jarman T
    J Pharm Pharm Sci; 2022; 25():323-339. PubMed ID: 36251699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®.
    Gasser UE; Fischer A; Timmermans JP; Arnet I
    BMC Pharmacol Toxicol; 2013 Apr; 14():24. PubMed ID: 23617953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution and in vivo evidence of differences in reference products: impact on development of generic drugs.
    Spino M; Tsang YC; Pop R
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):18-24. PubMed ID: 11032084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality Testing of Difficult-to-Make Prescription Pharmaceutical Products Marketed in the US.
    Fisher AC; Viehmann A; Ashtiani M; Friedman RL; Buhse L; Kopcha M; Woodcock J
    JAMA Netw Open; 2020 Aug; 3(8):e2013920. PubMed ID: 32833019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products.
    Mostafa HF; Ibrahim MA; Mahrous GM; Sakr A
    Saudi Pharm J; 2011 Apr; 19(2):123-7. PubMed ID: 23960750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug formulations intended for the global market should be tested for stability under tropical climatic conditions.
    Risha PG; Vervaet C; Vergote G; Bortel LV; Remon JP
    Eur J Clin Pharmacol; 2003 Jun; 59(2):135-41. PubMed ID: 12721773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of manufacturing practices on quality of pharmaceutical products manufactured in Kenya.
    Orwa JA; Keter LK; Ouko SP; Kibwage IO; Rukunga GM
    East Afr Med J; 2004 Jun; 81(6):287-92. PubMed ID: 16167675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey of the Regulatory Requirements for the Acceptance of Foreign Comparator Products by Participating Regulators and Organizations of the International Generic Drug Regulators Programme.
    Garcia Arieta A; Simon C; Lima Santos GM; Calderón Lojero IO; Rodríguez Martínez Z; Rodrigues C; Park SA; Kim JM; Kuribayashi R; Okada Y; Nolting A; Pfäffli C; Hung WY; Crane C; Braddy AC; Van Oudtshoorn J; Gutierrez Triana D; Clarke M
    J Pharm Pharm Sci; 2019; 22(1):28-36. PubMed ID: 30599818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing in vitro/in vivo assessment of fixed dose combination products of first line antiretrovirals.
    Joshi A; Esseku F; Silva L; Igwilo C; Oqua D; Kunle B; Obodozie O; Inyang U; Adeyeye MC
    J Pharm Sci; 2010 Jun; 99(6):2655-63. PubMed ID: 20054854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India.
    Singal GL; Nanda A; Kotwani A
    Indian J Pharmacol; 2011 Apr; 43(2):131-6. PubMed ID: 21572645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.